Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_assertion type Assertion NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_head.
- NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_assertion description "[These results suggest that CD123 CAR T cells are a promising immunotherapy for the treatment of high-risk AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_provenance.
- NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_assertion evidence source_evidence_literature NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_provenance.
- NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_assertion SIO_000772 24030378 NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_provenance.
- NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_assertion wasDerivedFrom befree-2016 NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_provenance.
- NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_assertion wasGeneratedBy ECO_0000203 NP1109985.RAw9RUJ0F3kLyEHCVsd_-9FQP4-102zSMOc7TkX3PPes0130_provenance.